Study on the Sex-specific, Lipid- and Lipoprotein-lowering Effects of Berberine

NCT06782646 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ENROLLING_BY_INVITATION

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Hyperlipidemia

Interventions

DRUG: Berberine
DRUG: Placebo

Sponsor

The University of Hong Kong